Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksORPH.L Regulatory News (ORPH)

  • There is currently no data for ORPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Open Orphan plc

14 Jan 2020 11:12



Form 8.3 - Open Orphan plc

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:Investec Wealth & Investment
(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree Open Orphan plc
(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A
(e) Date position held/dealing undertaken: For an opening position disclosure, state the latest practicable date prior to the disclosure 13th January 2020
(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer? If it is a cash offer or possible cash offer, state “N/A” No

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:  
InterestsShort positions
Number%Number%
(1) Relevant securities owned and/or controlled:5,260,0002.07%  
(2) Cash-settled derivatives:     
(3) Stock-settled derivatives (including options) and agreements to purchase/sell:    
TOTAL:5,260,0002.07%  

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists: 
Details, including nature of the rights concerned and relevant percentages: 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant securityPurchase/sale Number of securitiesPrice per unit
Ordinary SharesOrdinary Shares PurchasePurchase 1,120,00080,000 6.125p6.2p

(b) Cash-settled derivative transactions

Class of relevant securityProduct descriptione.g. CFDNature of dealinge.g. opening/closing a long/short position, increasing/reducing a long/short positionNumber of reference securitiesPrice per unit
     

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant securityProduct description e.g. call optionWriting, purchasing, selling, varying etc.Number of securities to which option relatesExercise price per unitTypee.g. American, European etc.Expiry dateOption money paid/ received per unit
        

(ii) Exercise

Class of relevant securityProduct descriptione.g. call optionExercising/ exercised againstNumber of securitiesExercise price per unit
    

(d) Other dealings (including subscribing for new securities)

Class of relevant securityNature of dealinge.g. subscription, conversionDetailsPrice per unit (if applicable)
    

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”
N/A

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:(i) the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:If there are no such agreements, arrangements or understandings, state “none”
N/A

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?NO

Date of disclosure:14th January 2020
Contact name:Phil Beardwell Chartered FCSI
Telephone number:020 7597 1356

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.


Date   Source Headline
10th May 20197:00 amRNSPreliminary Final Results
1st May 201911:00 amRNSChanges to interests of a significant shareholder
1st May 201911:00 amRNSIntegumen Debt Conversion
8th Apr 20197:00 amRNSFinancing Update
26th Mar 20197:00 amRNSChange of Adviser
21st Jan 20194:40 pmRNSSecond Price Monitoring Extn
21st Jan 20194:35 pmRNSPrice Monitoring Extension
18th Jan 20197:00 amRNSPartnership Announcement
24th Dec 201812:36 pmRNSPrice Monitoring Extension
21st Dec 20184:29 pmRNSDirector/PDMR Shareholding
20th Dec 20185:04 pmRNSHolding(s) in Company
11th Dec 20187:00 amRNSStrategic Collaboration Agreement and Financing
8th Nov 201810:40 amRNSTrading Update and Change of Adviser
5th Oct 20183:36 pmRNSHolding(s) in Company
25th Sep 20187:00 amRNSHalf-year Report
17th Sep 20187:00 amRNSFirst laboratory-grown human-skin test service
30th Jul 201811:27 amRNSHolding(s) in Company
26th Jul 20185:01 pmRNSHolding(s) in Company
26th Jul 20185:00 pmRNSHolding(s) in Company
26th Jul 20183:40 pmRNSHolding(s) in Company
24th Jul 20188:00 amRNSEnterprise Securities Market Notice
24th Jul 20188:00 amRNSEnterprise Securities Market Notice
20th Jul 20183:22 pmRNSResult of General Meeting
4th Jul 20187:00 amRNSPlacing & Subscription to raise up to £0.65m
28th Jun 201811:47 amRNSResult of AGM
6th Jun 20184:55 pmRNSNotice of AGM & Posting of Annual Report&Accounts
17th May 20187:00 amRNSFinal Results
23rd Apr 20187:00 amRNSNotice of Results
21st Mar 20187:00 amRNSDirectorate Change
15th Feb 20187:00 amRNSTrading Statement
25th Jan 20187:00 amRNSChange of Adviser
23rd Jan 20187:00 amRNSAcquisition of Minority Interest
14th Sep 20175:19 pmRNSGrant of Stock Options
12th Sep 20177:00 amRNSHalf-year Report
25th Jul 20177:00 amRNSSenior Management Appointment
20th Jul 20177:00 amRNSHalf year end update
26th Apr 20176:01 pmRNSResult of AGM
25th Apr 20173:13 pmRNSProposed amendment to AGM resolution
5th Apr 20177:00 amRNSIntegumen IPO
4th Apr 20177:00 amRNSEnterprise Securities Market Notice
31st Mar 201711:26 amRNSAnnual Financial Report & Notice of AGM
29th Mar 20171:57 pmRNSIssue of Equity
22nd Mar 20177:00 amRNSFinal Results
3rd Mar 20177:00 amRNSYear End Update
18th Nov 20167:00 amRNSCompletion of Sale
10th Nov 20165:51 pmRNSREPLACEMENT - Contract win
8th Nov 20167:00 amRNSContract win
2nd Nov 20167:03 amRNSDirector/PDMR Shareholding
27th Oct 20167:00 amRNSSale of Innovenn UK Limited and Result of GM
4th Oct 20167:00 amRNSSale of Innovenn & Notice of General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.